AME-133v

· Applied Molecular Evolution

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AME-133v, covering 2016-01-07 to 2016-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma [Phase 1]

See pricing